Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by Dachs1on Sep 19, 2017 4:05am

181 Views

Post# 26712363

LEI system / Important for European Investors

Info for European Investors:

Sirona has done the homework. Good!
Pepole with a European trading account can only trade a stock with LEI number after 2017.
https://www.gleif.org/lei/549300CQE1Q87IG6W210

History[edit]

The LEI system was developed by the G20,^[4] in response to the inability of financial institutions to identify organisations uniquely, so that their financial transactions in different national jurisdictions can be fully tracked.^[5] The first LEIs were issued in December 2012.^[6]

https://en.wikipedia.org/wiki/Legal_Entity_Identifier

Bullboard Posts

Boeing workers end strike, return to work